Two of India’s biggest tea companies, Goodricke Group Ltd and Duncans Industries Ltd, said they may plunge into losses as workers, backed by key political parties, agitate for more pay. The labour unions reject this contention. The two companies are the main plantation owners in West Bengal’s Dooars region and do not have too many gardens elsewhere. Between them they produce about 34 million kg of tea a year; Goodricke is...

-The Business Standard   Increasing newsprint prices are likely to have a negative impact on Profitability of the Indian print media industry in the short to medium term, according to a Fitch report. The report expects that an increase in advertising revenues may partly offset the rising cost of newsprint. Newspaper publishers generate about 70 percent of revenues from advertising, with the remainder coming predominantly from circulations. However, the agency's expectation of...

While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...

-The Economic Times   A group of ministers formed to approve the draft mining Bill, has agreed to earmark 100% of the royalty paid by major mineral mining companies , to compensate people displaced by such projects. The panel, chaired by finance minister Pranab Mukherjee , which met on Thursday , also agreed to earmark 26% of the profit made by coal mining companies, in favour of people directly affected ,...

India’s FTAs pip generic drugs production Lot More For Less     * Generic drugs from India play a major role as antiretroviral drugs across the developing world     * A 2010 study says 80% of the medicines used by donor-funded programmes to treat people with HIV were sourced from India     * It’s cut down treatment costs drastically, from $10,000 to $80     * Stronger IP regimes may hamper production of generics *** The right of...